D. Boral Capital Reaffirms “Buy” Rating for Medicus Pharma (NASDAQ:MDCX)
D. Boral Capital reaffirmed their buy rating on shares of Medicus Pharma (NASDAQ:MDCX – Free Report) in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has a $14.00 price objective on the stock. Separately, D Boral Capital upgraded Medicus Pharma to a “strong-buy” rating in a research report on Monday, April […]
D. Boral Capital reaffirmed their buy rating on shares of Medicus Pharma (NASDAQ:MDCX – Free Report) in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has a $14.00 price objective on the stock. Separately, D Boral Capital upgraded Medicus Pharma to a “strong-buy” rating in a research report on Monday, April […]
